CLINICAL_TRIALS
trial_result
· 2011-01-11
Clinical Trial Update: Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 clinical trial evaluating a Variable Bolus Regimen 1-2-3 for Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED